The role of peripherally acting µ-opioid receptor antagonists (PAMORAs) in the management of opioid-induced constipation (OIC)

Management of opioid-induced constipation

This educational reference document has been initiated, commissioned, and developed by Sandoz Ltd.

Information intended for UK healthcare professionals only.

View prescribing information. 


Date of preparation: September 2020

Content for healthcare professionals

Access to this content is restricted to UK-based doctors, nurses, and pharmacists

If you are a UK-based doctor, nurse, or pharmacist, you must sign in to your account or register (for free) if you do not already have one. 

Return to homepage